Where should biotech start-ups look for funding in the venture capital desert that is becoming the new normal?
The panel The New Kids on the Biotech Block: Trends in Early-Stage Financing kicked off the 11th Annual BIO Investor Forum and focused on non-traditional early-stage investors and deal structures.
Moderated by Jeron Eaves, a senior practice executive with Campbell Alliance, the panel highlighted companies that have secured financing from creative sources, like patient advocacy groups and venture philanthropists, as well as companies that have negotiated non-dilutive financing from traditional pharmas and VCs using innovative deal strategies.
To read the full, original article click on this link: BIO Investor Forum: The New Kids on the Biotech Block | BIOtechNow
